A conserved C-terminal sequence of high-risk cutaneous beta-human papillomavirus E6 proteins alters localization and signalling of β1-integrin to promote cell migration

Journal of General Virology

Volumn 95, Issue PART 1, 2014, Pages 123-134

  Holloway, Amy ^a   Storey, Alan ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; FOCAL ADHESION KINASE; PDZ PROTEIN; PROTEIN E6;

ACTIN FILAMENT; ARTICLE; BETA HUMAN PAPILLOMAVIRUS; CARBOXY TERMINAL SEQUENCE; CELL LEVEL; CELL MEMBRANE; CELL MIGRATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; KERATINOCYTE; NONHUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TARGETING; VIRUS CARCINOGENESIS; VIRUS MUTATION; WART VIRUS;

EID: 84890285640     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.057695-0     Document Type: Article

References (82)

1. Akgül, B., Zigrino, P., Frith, D., Hanrahan, S. & Storey, A. (2009). Proteomic analysis reveals the actin cytoskeleton as cellular target for the human papillomavirus type 8. Virology 386, 1-5.
2. Akgül, B., Bostanci, N., Westphal, K., Nindl, I., Navsaria, H., Storey, A. & Pfister, H. (2010). Human papillomavirus 5 and 8 E6 downregulate interleukin-8 secretion in primary human keratinocytes. J Gen Virol 91, 888-892.
3. Au Yeung, C. L., Tsang, T. Y., Yau, P. L. & Kwok, T. T. (2011). Human papillomavirus type 16 E6 induces cervical cancer cell migration through the p53/microRNA-23b/urokinase-type plasminogen activator pathway. Oncogene 30, 2401-2410.
4. Ben Khalifa, Y., Teissier, S., Tan, M. K., Phan, Q. T., Daynac, M., Wong, W. Q. & Thierry, F. (2011). The human papillomavirus E6 oncogene represses a cell adhesion pathway and disrupts focal adhesion through degradation of TAp63β upon transformation. PLoS Pathog 7, e1002256.
5. Brakebusch, C. & Fässler, R. (2005). β1 Integrin function in vivo: adhesion, migration and more. Cancer Metastasis Rev 24, 403-411.
6. Brakebusch, C., Grose, R., Quondamatteo, F., Ramirez, A., Jorcano, J. L., Pirro, A., Svensson, M., Herken, R., Sasaki, T. & other authors (2000). Skin and hair follicle integrity is crucially dependent on β1 integrin expression on keratinocytes. EMBO J 19, 3990-4003.
7. Brimer, N., Lyons, C., Wallberg, A. E. & Vande Pol, S. B. (2012). Cutaneous papillomavirus E6 oncoproteins associate with MAML1 to repress transactivation and NOTCH signaling. Oncogene 31, 4639-4646.
8. Carroll, J. M., Romero, M. R. & Watt, F. M. (1995). Suprabasal integrin expression in the epidermis of transgenic mice results in developmental defects and a phenotype resembling psoriasis. Cell 83, 957-968.
9. Chan, K. T., Cortesio, C. L. & Huttenlocher, A. (2007). Integrins in cell migration. Methods Enzymol 426, 47-67.
10. Charette, S. T. & McCance, D. J. (2007). The E7 protein from human papillomavirus type 16 enhances keratinocyte migration in an Aktdependent manner. Oncogene 26, 7386-7390.
11. Cornet, I., Bouvard, V., Campo, M. S., Thomas, M., Banks, L., Gissmann, L., Lamartine, J., Sylla, B. S., Accardi, R. & Tommasino, M. (2012). Comparative analysis of transforming properties of E6 and E7 from different beta human papillomavirus types. J Virol 86, 2366-2370.
12. de Villiers, E. M., Lavergne, D., McLaren, K. & Benton, E. C. (1997). Prevailing papillomavirus types in non-melanoma carcinomas of the skin in renal allograft recipients. Int J Cancer 73, 356-361.
13. Dickson, M. A., Hahn, W. C., Ino, Y., Ronfard, V., Wu, J. Y., Weinberg, R. A., Louis, D. N., Li, F. P. & Rheinwald, J. G. (2000). Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol Cell Biol 20, 1436-1447.
14. Diepgen, T. L. & Mahler, V. (2002). The epidemiology of skin cancer. Br J Dermatol 146 (Suppl 61), 1-6.
15. Du, J., Chen, X., Liang, X., Zhang, G., Xu, J., He, L., Zhan, Q., Feng, X. Q., Chien, S. & Yang, C. (2011). Integrin activation and internalization on soft ECM as a mechanism of induction of stem cell differentiation by ECM elasticity. Proc Natl Acad Sci U S A 108, 9466-9471.
16. Ezratty, E. J., Bertaux, C., Marcantonio, E. E. & Gundersen, G. G. (2009). Clathrin mediates integrin endocytosis for focal adhesion disassembly in migrating cells. J Cell Biol 187, 733-747.
17. Gardiol, D., Kühne, C., Glaunsinger, B., Lee, S. S., Javier, R. & Banks, L. (1999). Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation. Oncogene 18, 5487-5496.
18. Giampieri, S. & Storey, A. (2004). Repair of UV-induced thymine dimers is compromised in cells expressing the E6 protein from human papillomaviruses types 5 and 18. Br J Cancer 90, 2203-2209.
19. Goldenthal, K. L., Hedman, K., Chen, J. W., August, J. T. & Willingham, M. C. (1985). Postfixation detergent treatment for immunofluorescence suppresses localization of some integral membrane proteins. J Histochem Cytochem 33, 813-820.
20. Goldfinger, L. E., Hopkinson, S. B., deHart, G. W., Collawn, S., Couchman, J. R. & Jones, J. C. (1999). The α3 laminin subunit, α6β4 and α3β1 integrin coordinately regulate wound healing in cultured epithelial cells and in the skin. J Cell Sci 112, 2615-2629.
21. Grose, R., Hutter, C., Bloch, W., Thorey, I., Watt, F. M., Fässler, R., Brakebusch, C. & Werner, S. (2002). A crucial role of β1 integrins for keratinocyte migration in vitro and during cutaneous wound repair. Development 129, 2303-2315.
22. Gül, U., Kiliç, A., Gönül, M., Cakmak, S. K. & Bayis, S. S. (2007). Clinical aspects of epidermodysplasia verruciformis and review of the literature. Int J Dermatol 46, 1069-1072.
23. Hartevelt, M. M., Bavinck, J. N., Kootte, A. M., Vermeer, B. J. & Vandenbroucke, J. P. (1990). Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation 49, 506-509.
24. Harwood, C. A., Surentheran, T., McGregor, J. M., Spink, P. J., Leigh, I. M., Breuer, J. & Proby, C. M. (2000). Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol 61, 289-297.
25. Harwood, C. A., Surentheran, T., Sasieni, P., Proby, C. M., Bordea, C., Leigh, I. M., Wojnarowska, F., Breuer, J. & McGregor, J. M. (2004). Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin. Br J Dermatol 150, 949-957.
26. Hertle, M. D., Kubler, M. D., Leigh, I. M. & Watt, F. M. (1992). Aberrant integrin expression during epidermal wound healing and in psoriatic epidermis. J Clin Invest 89, 1892-1901.
27. Howie, H. L., Koop, J. I., Weese, J., Robinson, K., Wipf, G., Kim, L. & Galloway, D. A. (2011). Beta-HPV 5 and 8 E6 promote p300 degradation by blocking AKT/p300 association. PLoS Pathog 7, e1002211.
28. Hudson, J. B., Bedell, M. A., McCance, D. J. & Laiminis, L. A. (1990). Immortalization and altered differentiation of human keratinocytes in vitro by the E6 and E7 open reading frames of human papillomavirus type 18. J Virol 64, 519-526.
29. Huibregtse, J. M., Scheffner, M. & Howley, P. M. (1991). A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J 10, 4129-4135.
30. Humphries, J. D., Byron, A. & Humphries, M. J. (2006). Integrin ligands at a glance. J Cell Sci 119, 3901-3903.
31. Iftner, T., Elbel, M., Schopp, B., Hiller, T., Loizou, J. I., Caldecott, K. W. & Stubenrauch, F. (2002). Interference of papillomavirus E6 protein with single-strand break repair by interaction with XRCC1. EMBO J 21, 4741-4748.
32. Jackson, S. & Storey, A. (2000). E6 proteins from diverse cutaneous HPV types inhibit apoptosis in response to UV damage. Oncogene 19, 592-598.
33. Jackson, S., Harwood, C., Thomas, M., Banks, L. & Storey, A. (2000). Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins. Genes Dev 14, 3065-3073.
34. Jackson, S., Ghali, L., Harwood, C. & Storey, A. (2002). Reduced apoptotic levels in squamous but not basal cell carcinomas correlates with detection of cutaneous human papillomavirus. Br J Cancer 87, 319-323.
35. Jha, S., Vande Pol, S., Banerjee, N. S., Dutta, A. B., Chow, L. T. & Dutta, A. (2010). Destabilization of TIP60 by human papillomavirus E6 results in attenuation of TIP60-dependent transcriptional regulation and apoptotic pathway. Mol Cell 38, 700-711.
36. Jones, P. H. & Watt, F. M. (1993). Separation of human epidermal stem cells from transit amplifying cells on the basis of differences in integrin function and expression. Cell 73, 713-724.
37. Jones, D. L., Alani, R. M. & Münger, K. (1997). The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2. Genes Dev 11, 2101-2111.
38. Kim, L. T., Ishihara, S., Lee, C. C., Akiyama, S. K., Yamada, K. M. & Grinnell, F. (1992). Altered glycosylation and cell surface expression of beta 1 integrin receptors during keratinocyte activation. J Cell Sci 103, 743-753.
39. Kiviat, N. B. (1999). Papillomaviruses in non-melanoma skin cancer: epidemiological aspects. Semin Cancer Biol 9, 397-403.
40. Kiyono, T., Hiraiwa, A., Fujita, M., Hayashi, Y., Akiyama, T. & Ishibashi, M. (1997). Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein. Proc Natl Acad Sci U S A 94, 11612-11616.
41. Kühne, C., Gardiol, D., Guarnaccia, C., Amenitsch, H. & Banks, L. (2000). Differential regulation of human papillomavirus E6 by protein kinase A: conditional degradation of human discs large protein by oncogenic E6. Oncogene 19, 5884-5891.
42. Larjava, H., Salo, T., Haapasalmi, K., Kramer, R. H. & Heino, J. (1993). Expression of integrins and basement membrane components by wound keratinocytes. J Clin Invest 92, 1425-1435.
43. Lee, S. S., Glaunsinger, B., Mantovani, F., Banks, L. & Javier, R. T. (2000). Multi-PDZ domain protein MUPP1 is a cellular target for both adenovirus E4-ORF1 and high-risk papillomavirus type 18 E6 oncoproteins. J Virol 74, 9680-9693.
44. Marcuzzi, G. P., Hufbauer, M., Kasper, H. U., Weissenborn, S. J., Smola, S. & Pfister, H. (2009). Spontaneous tumour development in human papillomavirus type 8 E6 transgenic mice and rapid induction by UV-light exposure and wounding. J Gen Virol 90, 2855-2864.
45. McCormack, S. J., Brazinski, S. E., Moore, J. L., Jr, Werness, B. A. & Goldstein, D. J. (1997). Activation of the focal adhesion kinase signal transduction pathway in cervical carcinoma cell lines and human genital epithelial cells immortalized with human papillomavirus type 18. Oncogene 15, 265-274.
46. Mettouchi, A. & Meneguzzi, G. (2006). Distinct roles of β1 integrins during angiogenesis. Eur J Cell Biol 85, 243-247.
47. Michel, A., Kopp-Schneider, A., Zentgraf, H., Gruber, A. D. & de Villiers, E. M. (2006). E6/E7 expression of human papillomavirus type 20 (HPV-20) and HPV-27 influences proliferation and differentiation of the skin in UV-irradiated SKH-hr1 transgenic mice. J Virol 80, 11153-11164.
48. Moody, C. A. & Laimins, L. A. (2010). Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer 10, 550-560.
49. Nakagawa, S. & Huibregtse, J. M. (2000). Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase. Mol Cell Biol 20, 8244-8253.
50. Ng, T., Shima, D., Squire, A., Bastiaens, P. I., Gschmeissner, S., Humphries, M. J. & Parker, P. J. (1999). PKCα regulates β1 integrindependent cell motility through association and control of integrin traffic. EMBO J 18, 3909-3923.
51. Nguyen, M. L., Nguyen, M. M., Lee, D., Griep, A. E. & Lambert, P. F. (2003). The PDZ ligand domain of the human papillomavirus type 16 E6 protein is required for E6's induction of epithelial hyperplasia in vivo. J Virol 77, 6957-6964.
52. Nominé, Y., Masson, M., Charbonnier, S., Zanier, K., Ristriani, T., Deryckère, F., Sibler, A. P., Desplancq, D., Atkinson, R. A. & other authors (2006). Structural and functional analysis of E6 oncoprotein: insights in the molecular pathways of human papillomavirusmediated pathogenesis. Mol Cell 21, 665-678.
53. Orth, G. (1986). Epidermodysplasia verruciformis: a model for understanding the oncogenicity of human papillomaviruses. Ciba Found Symp 120, 157-174.
54. Pfister, H. (2003). Chapter 8: Human papillomavirus and skin cancer. J Natl Cancer Inst Monogr 2003, 52-56.
55. Pfister, H. & Ter Schegget, J. (1997). Role of HPV in cutaneous premalignant and malignant tumors. Clin Dermatol 15, 335-347.
56. Pim, D., Thomas, M., Javier, R., Gardiol, D. & Banks, L. (2000). HPV E6 targeted degradation of the discs large protein: evidence for the involvement of a novel ubiquitin ligase. Oncogene 19, 719-725.
57. Pim, D., Thomas, M. & Banks, L. (2002). Chimaeric HPV E6 proteins allow dissection of the proteolytic pathways regulating different E6 cellular target proteins. Oncogene 21, 8140-8148.
58. Proby, C. M., Harwood, C. A., Neale, R. E., Green, A. C., Euvrard, S., Naldi, L., Tessari, G., Feltkamp, M. C., de Koning, M. N. & other authors (2011). A case-control study of betapapillomavirus infection and cutaneous squamous cell carcinoma in organ transplant recipients. Am J Transplant 11, 1498-1508.
59. Rozenblatt-Rosen, O., Deo, R. C., Padi, M., Adelmant, G., Calderwood, M. A., Rolland, T., Grace, M., Dricot, A., Askenazi, M. & other authors (2012). Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. Nature 487, 491-495.
60. Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J. & Howley, P. M. (1990). The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63, 1129-1136.
61. Schober, M. & Fuchs, E. (2011). Tumor-initiating stem cells of squamous cell carcinomas and their control by TGF-β and integrin/ focal adhesion kinase (FAK) signaling. Proc Natl Acad Sci U S A 108, 10544-10549.
62. Shen, X., Li, C. C., Aponte, A. M., Shen, R. F., Billings, E. M., Moss, J. & Vaughan, M. (2012). Brefeldin A-inhibited ADP-ribosylation factor activator BIG2 regulates cell migration via integrin β1 cycling and actin remodeling. Proc Natl Acad Sci U S A 109, 14464-14469.
63. Sherman, L. & Schlegel, R. (1996). Serum-and calcium-induced differentiation of human keratinocytes is inhibited by the E6 oncoprotein of human papillomavirus type 16. J Virol 70, 3269-3279.
64. Simmonds, M. & Storey, A. (2008). Identification of the regions of the HPV 5 E6 protein involved in Bak degradation and inhibition of apoptosis. Int J Cancer 123, 2260-2266.
65. Simpson, C. L., Patel, D. M. & Green, K. J. (2011). Deconstructing the skin: cytoarchitectural determinants of epidermal morphogenesis. Nat Rev Mol Cell Biol 12, 565-580.
66. Sivamani, R. K., Garcia, M. S. & Isseroff, R. R. (2007). Wound re-epithelialization: modulating keratinocyte migration in wound healing. Front Biosci 12, 2849-2868.
67. Slack, J. K., Adams, R. B., Rovin, J. D., Bissonette, E. A., Stoker, C. E. & Parsons, J. T. (2001). Alterations in the focal adhesion kinase/Src signal transduction pathway correlate with increased migratory capacity of prostate carcinoma cells. Oncogene 20, 1152-1163.
68. Spangle, J. M. & Munger, K. (2013). The HPV16 E6 oncoprotein causes prolonged receptor protein tyrosine kinase signaling and enhances internalization of phosphorylated receptor species. PLoS Pathog 9, e1003237.
69. Stockfleth, E., Ulrich, C., Meyer, T., Arndt, R. & Christophers, E. (2001). Skin diseases following organ transplantation-risk factors and new therapeutic approaches. Transplant Proc 33, 1848-1853.
70. Storey, A., Thomas, M., Kalita, A., Harwood, C., Gardiol, D., Mantovani, F., Breuer, J., Leigh, I. M., Matlashewski, G. & Banks, L. (1998). Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 393, 229-234.
71. Tan, M. J., White, E. A., Sowa, M. E., Harper, J. W., Aster, J. C. & Howley, P. M. (2012). Cutaneous β-human papillomavirus E6 proteins bind Mastermind-like coactivators and repress notch signaling. Proc Natl Acad Sci U S A 109, E1473-E1480.
72. Thomas, M., Laura, R., Hepner, K., Guccione, E., Sawyers, C., Lasky, L. & Banks, L. (2002). Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation. Oncogene 21, 5088-5096.
73. Thomas, M., Massimi, P., Navarro, C., Borg, J. P. & Banks, L. (2005). The hScrib/Dlg apico-basal control complex is differentially targeted by HPV-16 and HPV-18 E6 proteins. Oncogene 24, 6222-6230.
74. Tomlins, C. & Storey, A. (2010). Cutaneous HPV5 E6 causes increased expression of osteoprotegerin and interleukin 6 which contribute to evasion of UV-induced apoptosis. Carcinogenesis 31, 2155-2164.
75. Vassilieva, E. V., Gerner-Smidt, K., Ivanov, A. I. & Nusrat, A. (2008). Lipid rafts mediate internalization of β1-integrin in migrating intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 295, G965-G976.
76. Wade, R., Brimer, N. & Vande Pol, S. (2008). Transformation by bovine papillomavirus type 1 E6 requires paxillin. J Virol 82, 5962-5966.
77. Wallace, N. A., Robinson, K., Howie, H. L. & Galloway, D. A. (2012). HPV 5 and 8 E6 abrogate ATR activity resulting in increased persistence of UVB induced DNA damage. PLoS Pathog 8, e1002807.
78. Wang, S., Pang, T., Gao, M., Kang, H., Ding, W., Sun, X., Zhao, Y., Zhu, W., Tang, X. & other authors (2013). HPV E6 induces eIF4E transcription to promote the proliferation and migration of cervical cancer. FEBS Lett 587, 690-697.
79. Watson, R. A., Thomas, M., Banks, L. & Roberts, S. (2003). Activity of the human papillomavirus E6 PDZ-binding motif correlates with an enhanced morphological transformation of immortalized human keratinocytes. J Cell Sci 116, 4925-4934.
80. Weissenborn, S., Neale, R. E., Waterboer, T., Abeni, D., Bavinck, J. N., Green, A. C., Harwood, C. A., Euvrard, S., Feltkamp, M. C. & other authors (2012). Beta-papillomavirus DNA loads in hair follicles of immunocompetent people and organ transplant recipients. Med Microbiol Immunol (Berl) 201, 117-125.
81. Werness, B. A., Levine, A. J. & Howley, P. M. (1990). Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248, 76-79.
82. Zhang, Y., Dasgupta, J., Ma, R. Z., Banks, L., Thomas, M. & Chen, X. S. (2007). Structures of a human papillomavirus (HPV) E6 polypeptide bound to MAGUK proteins: mechanisms of targeting tumor suppressors by a high-risk HPV oncoprotein. J Virol 81, 3618-3626.